Zobrazeno 1 - 10
of 211
pro vyhledávání: '"K Govind, Babu"'
Autor:
K Govind Babu, Aparna Sreevatsa
Publikováno v:
APIK Journal of Internal Medicine, Vol 10, Iss 3, Pp 143-145 (2022)
Externí odkaz:
https://doaj.org/article/ddc079ae74234f10958ae83a83bebaf9
Autor:
Raja Thirumalairaj, Purvish M. Parikh, Amit Agarwal, Randeep Singh, Arvind Krishnamurthy, Sharad S. Desai, Amita Maheshwari, Prashant Mehta, Abdul Ghafur, S. P. Somashekhar, Ahamed Iqbal, Dhairyasheel N. Savant, Syed Md Akram Hussain, Amit Bhatt, Tashi Wangdi, Jyoti Bajpai, Anantbhushan A. Ranade, K. Govind Babu, Ajay Bapna, Ghanshyam Biswas, Hemant Malhotra, M. Vamshi Krishna, Rajendra Prasad Baral, Rajesh Vashishtha, Ahmad Javid Safi, Sharmila Agarwal, J. P. Agarwal, Krishna Kumar Rathnam, P. N. Mohapatra, Rajeev Vijay Kumar, Senthil Rajappa, Sewanti Atul Limaye, Amish Vora, Vijay A.P. Reddy, Bhavesh B. Parekh, G. K. Rath
Publikováno v:
South Asian Journal of Cancer, Vol 10, Iss 01, Pp 03-08 (2021)
We provide the South Asian Declaration, containing the consensus guidelines for coronavirus disease 2019 (COVID-19) vaccination in cancer patients.
Externí odkaz:
https://doaj.org/article/e4c4ceebd616401184eba80b615aacea
Publikováno v:
Indian Journal of Surgical Oncology; 2024 Suppl 2, Vol. 15, p315-321, 7p
Autor:
Debu Tripathy, Tristan Curteis, Sara Hurvitz, Denise Yardley, Fabio Franke, K. Govind Babu, Paul Wheatley-Price, Young-Hyuck Im, Radost Pencheva, Lucy A. Eddowes, Pierre-Alexandre Dionne, David Chandiwana, Purnima Pathak, Brad Lanoue, Nadia Harbeck
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: The phase III MONALEESA-7 trial (NCT02278120) assessed ribociclib + endocrine therapy (ET) versus ET in premenopausal women with HR+/HER2− advanced breast cancer (ABC). The relationship between work productivity loss (WPL) and domains o
Externí odkaz:
https://doaj.org/article/e556612c8173402c97858b12d8f65714
Autor:
R Nanda, Aradhana Katke, N Suneetha, B Thejaswini, Tanvir Pasha, K P Jagannath, G V Giri, K Govind Babu
Publikováno v:
South Asian Journal of Cancer, Vol 8, Iss 3, Pp 178-182 (2019)
Introduction: The chemotherapy schedules with cytotoxic dose or weekly regimes are still challenging, weighing the benefits versus toxicities. This prospective randomized study is an attempt to assess the efficacy of two schedules of cisplatin in man
Externí odkaz:
https://doaj.org/article/7106446d0ac842f8aead889553c68a35
Autor:
Eugen Tausch, Philipp Beck, Richard F. Schlenk, Billy J. Jebaraj, Anna Dolnik, Deyan Y. Yosifov, Peter Hillmen, Fritz Offner, Ann Janssens, K. Govind Babu, Sebastian Grosicki, Jiri Mayer, Panagiotis Panagiotidis, Astrid McKeown, Ira V. Gupta, Alexandra Skorupa, Celine Pallaud, Lars Bullinger, Daniel Mertens, Hartmut Döhner, Stephan Stilgenbauer
Publikováno v:
Haematologica, Vol 105, Iss 10 (2020)
Next generation sequencing studies in Chronic lymphocytic leukemia (CLL) have revealed novel genetic variants that have been associated with disease characteristics and outcome. The aim of this study was to evaluate the prognostic value of recurrent
Externí odkaz:
https://doaj.org/article/36cf02f355d94d7a8bdbd704903512c5
Autor:
K Govind Babu, Tamojit Chaudhuri, K C Lakshmaiah, Lokanatha Dasappa, Linu Abraham Jacob, M C Suresh Babu, A H Rudresha, K N Lokesh, L K Rajeev
Publikováno v:
South Asian Journal of Cancer, Vol 7, Iss 1, Pp 11-15 (2018)
Background: Health-related quality of life (HRQOL) is an important oncologic end point for upper gastrointestinal malignancies. Unfortunately, till date, there is no published prospective data from India, comparing the HRQOL parameters between first-
Externí odkaz:
https://doaj.org/article/c8d5061aa99a4b17ad59cda725c18006
Autor:
K Govind Babu, Tamojit Chaudhuri, K C Lakshmaiah, Lokanatha Dasappa, Linu Abraham Jacob, M C Suresh Babu, A H Rudresha, K N Lokesh, L K Rajeev
Publikováno v:
South Asian Journal of Cancer, Vol 8, Iss 2, Pp 85-87 (2019)
Background: Epirubicin, cisplatin, and 5-FU (ECF) is one of the most commonly used first-line chemotherapy regimens in metastatic gastric cancer. However, due to protracted infusion schedule, need for special infusion pumps, and catheter-related comp
Externí odkaz:
https://doaj.org/article/35aeb62a5fd2473fa9a5123722c38097
Autor:
M C Suresh Babu, Tamojit Chaudhuri, K Govind Babu, K C Lakshmaiah, D Lokanatha, Linu Abraham Jacob, A H Rudresha, K N Lokesh, L K Rajeev
Publikováno v:
South Asian Journal of Cancer, Vol 6, Iss 3, Pp 118-121 (2017)
Background: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. Historically, a poor prognosis for metastatic disease has been reported with systemic chemotherapy. Significant advances have
Externí odkaz:
https://doaj.org/article/7dd5ffc46ff34323a38aa35eec10a260
Publikováno v:
Asian Journal of Oncology, Vol 03, Iss 01, Pp 087-091 (2017)
De novo (pretreatment) epidermal growth factor receptor T790M mutation in non-small-cell lung cancer (NSCLC) is rare when detected by standard genotyping methods. We present a case of concurrent de novo T790M and L858R mutations detected by direct se
Externí odkaz:
https://doaj.org/article/7c8d26995d7a424890d8bd8dc9f00a28